SIM
TPI

Spark Investment Management’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Spark Investment Management’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-19,500
Closed -$14K – 823
2014
Q4 		$14K Hold
19,500
– – ﹤0.01% 678
2014
Q3 		$12K Sell
19,500
-2,800
-13% -$1.77K ﹤0.01% 660
2014
Q2 		$16K Sell
22,300
-3,600
-14% -$2.85K ﹤0.01% 621
2014
Q1 		$25K Sell
25,900
-14,800
-36% -$14.8K ﹤0.01% 664
2013
Q4 		$32K Buy
+40,700
New +$37.4K 0.01% 631

Other funds holding TPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAM
Pope Asset Management Memphis, Tennessee $162M AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Spark Investment Management's TPI Position: Q1 2015 in Review

Spark Investment Management sold out of TIANYIN PHARMACEUTICAL (TPI) in Q1 2015, closing a stake of 19,500 shares — an estimated $14K sold.

Spark Investment Management first reported a position in TPI in Q4 2013 and held it in 5 quarters. The position peaked at $32K in Q4 2013. 9 funds tracked by Wall St. Rank hold TPI as of Q1 2015.

  • Spark Investment Management reported no remaining TIANYIN PHARMACEUTICAL position as of Q1 2015 after selling out during the quarter.
  • Spark Investment Management sold 19,500 TIANYIN PHARMACEUTICAL shares in Q1 2015, an estimated $14K.
  • Spark Investment Management first reported a position in TIANYIN PHARMACEUTICAL in Q4 2013 and held it in 5 quarters.
  • Spark Investment Management's TIANYIN PHARMACEUTICAL position peaked at $32K in Q4 2013.
  • 9 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q1 2015.

Based on Spark Investment Management's 13F filing for Q1 2015, filed 12 May 2015.